Laboratorio Farmaceutico Erfo SpA (ERFO)

Currency in EUR
1.24
+0.01(+0.41%)
Closed·
ERFO Scorecard
Full Analysis
Net income is expected to grow this year
ERFO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.201.24
52 wk Range
0.881.70
Key Statistics
Prev. Close
1.23
Open
1.22
Day's Range
1.2-1.24
52 wk Range
0.88-1.7
Volume
11K
Average Volume (3m)
17.5K
1-Year Change
16.59%
Book Value / Share
0.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ERFO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.08
Upside
+67.74%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Laboratorio Farmaceutico Erfo SpA Company Profile

Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and packaging services. The company was founded in 2013 and is based in Villafranca Tirrena, Italy.

Employees
41
Market
Italy

Compare ERFO to Peers and Sector

Metrics to compare
ERFO
Peers
Sector
Relationship
P/E Ratio
29.9x19.0x12.2x
PEG Ratio
−0.750.020.03
Price/Book
1.4x2.0x1.5x
Price / LTM Sales
1.7x0.9x0.9x
Upside (Analyst Target)
69.1%8.9%17.5%
Fair Value Upside
Unlock11.9%10.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.08
(+67.74% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.04%
Dividend Yield
-
Industry Median 2.66%
Annualised payout
-
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 14, 2025
EPS / Forecast
0.01 / --
Revenue / Forecast
2.83M / --
EPS Revisions
Last 90 days

ERFO Income Statement

People Also Watch

19.770
PST
+1.02%
18.430
IVG
+0.44%
15.315
AMPF
+1.56%
1.96
CVG
-2.00%
2.50
VNE
+0.81%

FAQ

What Stock Exchange Does Laboratorio Farmaceutico Erfo Trade On?

Laboratorio Farmaceutico Erfo is listed and trades on the Milan Stock Exchange stock exchange.

What Is the Stock Symbol for Laboratorio Farmaceutico Erfo?

The stock symbol for Laboratorio Farmaceutico Erfo is "ERFO."

What Is the Laboratorio Farmaceutico Erfo Market Cap?

As of today, Laboratorio Farmaceutico Erfo market cap is 10.55M.

What Is Laboratorio Farmaceutico Erfo's Earnings Per Share (TTM)?

The Laboratorio Farmaceutico Erfo EPS (TTM) is 0.04.

From a Technical Analysis Perspective, Is ERFO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Laboratorio Farmaceutico Erfo Stock Split?

Laboratorio Farmaceutico Erfo has split 0 times.

How Many Employees Does Laboratorio Farmaceutico Erfo Have?

Laboratorio Farmaceutico Erfo has 41 employees.

What is the current trading status of Laboratorio Farmaceutico Erfo (ERFO)?

As of 07 Aug 2025, Laboratorio Farmaceutico Erfo (ERFO) is trading at a price of 1.24, with a previous close of 1.23. The stock has fluctuated within a day range of 1.20 to 1.24, while its 52-week range spans from 0.88 to 1.70.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.